The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 01, 2021

Filed:

May. 14, 2020
Applicant:

Centivax, Inc., South San Francisco, CA (US);

Inventors:

Jacob Glanville, San Francisco, CA (US);

Shahrad Daraeikia, San Francisco, CA (US);

I-Chieh Wang, San Bruno, CA (US);

Sindy Andrea Liao-Chan, San Jose, CA (US);

Assignee:

Centivax, Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/42 (2006.01); C07K 16/10 (2006.01); G01N 33/68 (2006.01); A61P 31/14 (2006.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07K 16/10 (2013.01); A61P 31/14 (2018.01); G01N 33/6854 (2013.01); A61K 45/06 (2013.01); A61K 2039/505 (2013.01); C07K 2317/565 (2013.01); C07K 2317/92 (2013.01);
Abstract

This disclosure provides superhuman antibodies and antigen-binding fragments that can be administered to an individual that is infected or suspected of being infected with a virus. Superhuman antibodies and antigen-binding fragments provided herein can be capable of treating or curing the virus, and which may provide protection against the virus for up to at least several weeks. Superhuman antibodies and antigen-binding fragments provided herein can be used to diagnose a SARS Cov-2 infection.


Find Patent Forward Citations

Loading…